EXAS240719P67500
- 8.60
- 0.000.00%
Exact Sciences Newsroom
Piper Sandler Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $80
Exact Sciences (EXAS) Receives a Buy From Piper Sandler
Express News | Exact Sciences Corp : Bernstein Raises Target Price to $83 From $81
Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights
Exact Sciences Is Maintained at Buy by Goldman Sachs
Express News | Goldman Sachs Maintains Buy on Exact Sciences, Lowers Price Target to $75
Exact Sciences Awards Grants to 28 Organizations Focused on Increasing Colorectal Cancer Screening
Exact Sciences Corporation (EXAS) Slipped Over Investors' Concerns
These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird
Exact Sciences Schedules Second Quarter 2024 Earnings Call
People Are Feeling Stuck in Their Jobs. Bosses Are Starting to Worry. -- WSJ
Exact Sciences Price Target Cut to $72.00/Share From $80.00 by Evercore ISI Group
Exact Sciences Is Maintained at Outperform by Evercore ISI Group
Exact Sciences Analyst Ratings
Evercore Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $72
Express News | Geneoscopy: Confident Litigation Will Not Delay Commercial Launch of Colosense
Express News | Geneoscopy: Files Counterclaims Against Exact Sciences
Exact Sciences Initiated at Sector Outperform at Scotiabank on Advanced Diagnostics
Exact Sciences Initiated at Sector Outperform by Scotiabank
Jefferies Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $75